Drugs / autologous dendritic cells loaded with autologous tumour homogenate
autologous dendritic cells loaded with autologous tumour homogenate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02919644 | Dec 2016 → Dec 2026 expected | colorectal cancer | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous dendritic cells loaded with autologous tumour homogenate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02919644 ↗ |
| Modality | Cell therapy | “Vaccination with autologous dendritic cells loaded with autologous tumour homogenate” NCT02919644 ↗ |
| Route | Other | “autologous dendritic cells loaded with autologous tumour homogenate given by intradermal injection” NCT02919644 ↗ |